This study found a significant dose-dependent association between arsenic exposure and RCC risk, with NLRP3 polymorphisms increasing susceptibility to RCC in individuals with elevated total urinary arsenic (108). The gene discussed is NLRP3; the disease is renal cell carcinoma.